OverviewSuggest Edit

Elanix Biotechnologies develops and commercializes products for acute wound care, dermatological and gynecological applications. The Company develops and markets progenitor cell-based products that are used to regenerate tissue and promote healing in the treatment of burns, and gynecological and dermatological conditions. Its products include GYNrepair, a cream for genital external mucosa, and SKINrepair, a cream for skin that protects against external aggressions. Elanix Biotechnologies is also developing FirstCover, an acute wound care tissue engineering product that is used to provide protection and healing for burns, and trauma and plastic surgery. The Company offers cell technology services as well. 

TypePublic
Founded2012
HQFrankfurt am Main, DE
Websiteelanixbiotechnologies.ch

Recent NewsAll News

Latest Updates

Employees (est.) (Feb 2019)11(+23%)
Revenue (FY, 2018)€62 K
Share Price (Apr 2022)€0.2(-15%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Elanix Biotechnologies

Tomas J. Svoboda

Tomas J. Svoboda

CEO

Elanix Biotechnologies Office Locations

Elanix Biotechnologies has offices in Frankfurt am Main, Epalinges and Nyon
Frankfurt am Main, DE (HQ)
Hanauer Landstraße 291B
Epalinges, CH
Route de la Corniche 4
Nyon, CH
10 Chemin du Joran
Show all (3)

Elanix Biotechnologies Financials and Metrics

Elanix Biotechnologies Revenue

Elanix Biotechnologies's revenue was reported to be €62 k in FY, 2018
EUR

Revenue (H1, 2019)

3.0k

Gross profit (H1, 2019)

103.0k

Net income (H1, 2019)

(609.0k)

EBITDA (H1, 2019)

(207.0k)

EBIT (H1, 2019)

(213.0k)

Market capitalization (27-Apr-2022)

4.3m

Closing stock price (27-Apr-2022)

0.2

Cash (30-Jun-2019)

39.0k

EV

4.3m
Elanix Biotechnologies's current market capitalization is €4.3 m.
Annual
EURFY, 2018

Revenue

62.0k

Cost of goods sold

(281.0k)

Gross profit

(213.0k)

R&D expense

(321.0k)
Half Year
EURH1, 2019

Revenue

3.0k

Gross profit

103.0k

R&D expense

(4.0k)
Annual
EURFY, 2018

Cash

20.0k

Accounts Receivable

30.0k
Half Year
EURH1, 2019

Cash

39.0k

Accounts Receivable

26.0k
Annual
EURFY, 2018
Half Year
EURH1, 2019
Show all financial metrics

Elanix Biotechnologies Revenue Breakdown

Embed Graph

Elanix Biotechnologies revenue breakdown by business segment: 100.0% from COSMETIC CREAMS

Elanix Biotechnologies Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Elanix Biotechnologies Online and Social Media Presence

Embed Graph

Elanix Biotechnologies Blogs

NOVEMBER BUSINESS UPDATE (ENG, DE, FR)

Ladies and Gentlemen, The 2018 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe congress in Berlin was very successful for Elanix’ GYNrepair® team. The DGGG congress was a great opportunity for us to showcase our technology and offer congress participants the possibility to get more informatio…

October Business Update (ENG, DE, FR)

Ladies and Gentlemen, As of October 1st, we formally closed a capital increase. A total of 301,763 shares were placed at a subscription price of EUR 2.75 resulting in gross proceeds of EUR 829,848. These gross process will be used to finance the company’s growth strategy and the launch of our new Ad…

Elanix Biotechnologies Frequently Asked Questions

  • When was Elanix Biotechnologies founded?

    Elanix Biotechnologies was founded in 2012.

  • Who are Elanix Biotechnologies key executives?

    Elanix Biotechnologies's key executives are Tomas J. Svoboda.

  • How many employees does Elanix Biotechnologies have?

    Elanix Biotechnologies has 11 employees.

  • What is Elanix Biotechnologies revenue?

    Latest Elanix Biotechnologies annual revenue is €62 k.

  • What is Elanix Biotechnologies revenue per employee?

    Latest Elanix Biotechnologies revenue per employee is €5.6 k.

  • Who are Elanix Biotechnologies competitors?

    Competitors of Elanix Biotechnologies include E-Qure, InspireMD and Soligenix.

  • Where is Elanix Biotechnologies headquarters?

    Elanix Biotechnologies headquarters is located at Hanauer Landstraße 291B, Frankfurt am Main.

  • Where are Elanix Biotechnologies offices?

    Elanix Biotechnologies has offices in Frankfurt am Main, Epalinges and Nyon.

  • How many offices does Elanix Biotechnologies have?

    Elanix Biotechnologies has 3 offices.